Aeglea BioTherapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Aeglea BioTherapeutics's balance sheet done over the years? Its assets were worth $71,144,000 last year, which is less than in the previous period. 29% of Aeglea BioTherapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $20,839,000, which means an decrease by -20% compared compared to last year.
Debt to Assets
| 2013 | 4597000 | 1.41M | 30.72% |
|---|---|---|---|
| 2014 | 2930000 | 1.05M | 36.11% |
| 2015 | 38654000 | 2.55M | 6.6% |
| 2016 | 67063000 | 4.09M | 6.11% |
| 2017 | 56077000 | 5.74M | 10.24% |
| 2018 | 77739000 | 10.31M | 13.26% |
| 2019 | 83183000 | 23.10M | 27.77% |
| 2020 | 161618000 | 21.78M | 13.48% |
| 2021 | 109926000 | 25.98M | 23.64% |
| 2022 | 71144000 | 20.83M | 29.29% |
AGLE Balance Sheet (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 34.86M | 15.14M | 90.09M | 19.25M | 22.46M | 12.81M | 47.74M | 29.29M | 2.61M | 4.59M |
Short term investments | 20.84M | 77.98M | 56.17M | 52.69M | 52.05M | 37.48M | 15.75M | 3.76M | 0 | 0 |
Net receivables | 375K | 815K | 0 | 0 | 0 | 3.07M | 1.21M | 1.69M | 0 | 0 |
Inventory | 0 | -815K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other current assets | 6.17M | 5.76M | 3.51M | 2.55M | 2.15M | 0 | 0 | 0 | 0 | 0 |
Total current assets | 62.25M | 98.89M | 149.78M | 74.50M | 76.67M | 54.99M | 66.42M | 38.28M | 2.73M | 4.59M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 6.65M | 8.35M | 9.87M | 7.11M | 1.01M | 854K | 599K | 348K | 162K | 0 |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 2.23M | 2.68M | 1.95M | 1.56M | 50K | 232K | 40K | 20K | 38K | 0 |
Total non-current assets | 8.88M | 11.03M | 11.82M | 8.67M | 1.06M | 1.08M | 639K | 368K | 200K | 0 |
Total assets | 71.14M | 109.92M | 161.61M | 83.18M | 77.73M | 56.07M | 67.06M | 38.65M | 2.93M | 4.59M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 517K | 2.35M | 13.40M | 14.38M | 0 | 20K | 71K | 0 | 0 | 0 |
Short term debt | 625K | 436K | 319K | 351K | 0 | 5.06M | 3.49M | 0 | 0 | 0 |
Total current liabilities | 14.65M | 20.14M | 16.44M | 18.35M | 10.23M | 5.62M | 3.96M | 2.52M | 1.05M | 1.41M |
| Non-current liabilities: | ||||||||||
Long term debt | 4.00M | 4.60M | 5.12M | 4.71M | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 16K | 214K | 31K | 72K | 111K | 132K | 27K | 0 | 0 |
Total non-current liabilities | 6.18M | 5.84M | 5.34M | 4.74M | 72K | 111K | 132K | 27K | 0 | 217K |
Total liabilities | 20.83M | 25.98M | 21.78M | 23.10M | 10.31M | 5.74M | 4.09M | 2.55M | 1.05M | 1.41M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |